DOCUSIGN, INC. — Director's Dealing 2020

Sep 22, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DOCUSIGN, INC. (DOCU)
CIK: 0001261333
Period of Report: 2020-09-18

Reporting Person: Salem Enrique T (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-18	Common Stock	S	5808	$188.8666	Disposed	1368491	Indirect
2020-09-18	Common Stock	S	9616	$189.7985	Disposed	1358875	Indirect
2020-09-18	Common Stock	S	8263	$190.7125	Disposed	1350612	Indirect
2020-09-18	Common Stock	S	7300	$191.7189	Disposed	1343312	Indirect
2020-09-18	Common Stock	S	4897	$192.6738	Disposed	1338415	Indirect
2020-09-18	Common Stock	S	1700	$193.7729	Disposed	1336715	Indirect
2020-09-18	Common Stock	S	11715	$194.9724	Disposed	1325000	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	166093	Direct

Footnotes

F1: Represents shares of Common Stock held directly by BCIP Venture Associates ("BCIP Venture"), BCIP Venture Associates-B ("BCIP Venture-B"), BCIP Venture Associates II, L.P. ("BCIP Venture II"), BCIP Venture Associates II-B, L.P. ("BCIP Venture II-B"), Bain Capital Venture Fund 2014, L.P. ("Venture Fund 2014"), Bain Capital Venture Partners 2014, L.P. ("Venture Partners 2014"), Bain Capital Venture Coinvestment Fund, L.P. ("Coinvestment Fund") and Bain Capital Venture Coinvestment Partners, L.P. ("Coinvestment Partners" and, collectively, the "Bain Venture Entities").

F2: Bain Capital Venture Investors, LLC ("BCVI") is (i) the general partner of Venture Partners 2014 and Coinvestment Partners, (ii) the ultimate general partner of Venture Fund 2014 and Coinvestment Fund and (iii) governs the investment strategy and decision making process with respect to investments held by each of BCIP Venture, BCIP Venture-B, BCIP Venture II and BCIP Venture II-B. Mr. Salem is a member of the Executive Committee and a Managing Director of BCVI. By virtue of the relationships described in this footnote, Mr. Salem may be deemed to share voting and dispositive power with respect to all of the shares of Common Stock held by the Bain Venture Entities. Mr. Salem disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.22 to $189.18, inclusive. The reporting person undertakes to provide to DocuSign, Inc., any security holder of DocuSign, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (9) to this Form 4.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.24 to $190.22, inclusive.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.25 to $191.24, inclusive.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.27 to $192.25, inclusive.

F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.28 to $193.15, inclusive.

F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.31 to $194.06, inclusive.

F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.50 to $195.25, inclusive.